Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis

Clinical Science

Volumn 90, Issue 5, 1996, Pages 393-401

  Wapstra, Frits H ^a   Van Goor, Harry ^a   Navis, Gerjan ^a   De Jong, Paul E ^a   De Zeeuw, Dick ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blood pressure; Doxorubicin; Glomerulosclerosis; Lisinopril; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; LISINOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG MECHANISM; GLOMERULOSCLEROSIS; KIDNEY INJURY; MALE; NEPHROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; SODIUM DEPLETION; SODIUM INTAKE;

EID: 0029944425     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900393     Document Type: Article

References (43)

1. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 74: 612-19.
2. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of ACE-inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
3. Beukers JJ, van der Wal A, Hoedemaeker PJ, Weening JJ. Converting enzyme inhibition and progressive glomerulosclerosis in the rat. Kidney Int 1987; 32: 794-800.
4. Brunner FP, Thiel G, Hermle M, Bock HA, Mihatsch MJ. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int 1989; 36: 969-77.
5. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-30.
6. Dworkin LD, Grosser M, Feiner HD, Ullian M, Parker M. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int 1989; 35: 790-8.
7. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 1988; 82: 1757-68.
8. Herlitz H, Edeno C, Mulec H, Westberg G, Aurell M. Captopril treatment of hypertension and renal failure in systemic lupus erythematosis. Nephron 1984; 38: 253-4.
9. Taguma Y, Kitamoto Y, Futaki G. Effect of captopril on heavy proteinuria in azotemic diabetes. N Engl J Med 1984; 313: 1617-20.
10. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987; 31: 78-83.
11. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE-inhibition by lisinopril. Kidney Int 1989; 36: 272-79.
12. Mann JFE, Reisch C, Ritz E. Use of ACE-inhibitors for the preservation of kidney function: a retrospective study. Nephron 1990; 55: S38-42.
13. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? [Editorial]. Kidney Int 1990; 38: 384-94.
14. Jackson B, Collins Cl. The contribution of systemic hypertension to progression of chronic renal failure in the remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 1988; 6: 495-501.
15. Hall RL, Wilke WL, Fettmann MJ. The progression of adriamycin induced nephrotic syndrome in rats and the effect of captopril. Toxicol Appl Pharmacol 1986; 81: 164-74
16. Scholey JW, Miller PL, Rennke HG, Meyer TW. Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy. Kidney Int 1989; 36: 816-22.
17. Beukers JJ, van der Wal A, Hoedemaeker PJ, Weening JJ. Converting enzyme inhibition and progressive glomerulosclerosis in the rat. Kidney Int 1987; 32: 794-800.
18. Beukers JJ, Hoedemaker PJ, Weening JJ. A comparison of the effects of converting enzyme inhibition and protein restriction in the experimental nephrosis. Lab Invest 1988; 59: 631-40.
19. Gansevoort, RT, Wapstra FH, Weening JJ, de Jong PE, de Zeeuw D. Sodium depletion enhances the antiproteinuric effect of ACE-inhibition in established experimental nephrosis. Nephron 1992; 60: 246-7.
20. Bunag RD. Measurement of blood pressure in rats. In: W. de Jong, ed. Handbook of hypertension. Amsterdam: Elsevier Science Publishers, 1984: 1-12.
21. van Goor H, van der Horst MLC, Fidler V, Grond J. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest 1992; 64: 564-71.
22. Raij L, Azar S, Keane WF. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137-41.
23. Hutchison F, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting enzyme inhibition. Am J Physiol 1987; 253: F719-25.
24. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-9.
25. Anderson S, Rennke HG, Brenner BM. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. J Hypertens 1986; 4 (Suppl. 5): S242-4.
26. Keane WF, Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G. ACE-inhibitors and progressive renal insufficiency. Ann Intern Med 1989; 111: 503-16.
27. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-66.
28. Olsen JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982; 22: 112-26.
29. Williams PC, Fase G, Boon JM. Renal pathology and proteinuria determine progression in untreated mild to moderate chronic renal failure. Q J Med 1988; 252: 343-5.
30. Navis GJ, de Jong PE, Donker AJM, van der Hem GK, de Zeeuw D. Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition. Kidney Int 1987; 31: 815-19.
31. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1992; 40: 195-202.
32. Cushman DW, Wang FL, Fung WC, et al. Comparison in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme. Br J Clin Pharmacol 1989; 28: 115-31S.
33. Apperloo AJ, de Zeeuw D, de Jong PE. Short term antiproteinuric response to antihypertensive treatment predicts long term GFR decline in patients with non diabetic renal disease. Kidney Int 1994; 45: 174-8.
34. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990; 85: 541-9.
35. van Goor H, Fidler V, Weening JJ, Grond J. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. Lib Invest 1991; 64: 754-65.
36. Keane WF, Kasiske BL, O'Donnell MP. The role of lipids in progressive glomerular disease. Adv Exp Med Biol 1987; 223P: 81-7.
37. Kasiske BL, O'Donnell MP, Schmitz PG. Renal injury of diet induced hypercholesterolaemia in rats. Kidney Int 1990; 37: 880-91.
38. Diamond JR, Karnovsky MJ. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 1987; 31: 671-77.
39. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 1988; 62: 367-74.
40. Diamond JR, Hanchak NA, McCarter MD, Karnovsky MJ. Cholestyramine resin ameliorates chronic aminonucleoside nephrosis. Am J Clin Nutr 1990; 51: 606-11.
41. Sakemi T, Baba N, Yoshikawa Y. Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic imai rats. Nephron 1992; 62: 315-21.
42. O'Donnell MP, Kasiske BL, Schmitz PG, Keane WF. High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics. Kidney Int 1990; 37: 1263-9.
43. Lax DS, Benstein JA, Tolbert E, Dworkin LD. Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 1992; 41: 1527-34.